Registered entities
Bivictrix Limited
Reg. No. 10005270United Kingdom
Innovation
4 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 32 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
Social engagement
Social engagement: 3.9K social following, 9 posts in the last 12 months — around the industry typical range.
Investor mix
7 investors on record; lead investors include Acceleris Capital, Development Bank of Wales, BioCity.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 29% |
| Private equity | 1 | 14% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 3 | 43% |
Recent activity
30 Jun 2026
Event
14th Antibody Industrial Symposium
24 Jun 2026
Event
14th Annual Antibody Symposium
13 May 2026
Event
Antibody Engineering & Therapeutics Europe